The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 15)
Stocks That Hit 52-Week Lows On Thursday
During the morning session on Thursday, 152 stocks hit new 52-week lows.
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 14)
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Delcath Systems (NASDAQ:DCTH) stock increased by 8.87% to $11.9 during Friday's after-market session. This security traded at a volume of 379 shares come close, making up 0.45% of its average volume over the last 100 days. The company's market cap stands at $87.4 million.
DFFN: TSC Causes Dose Dependent Increase in Tissue Oxygenation in TCOM Trial…
By David Bautz, PhD
NASDAQ:DFFN
READ THE FULL DFFN RESEARCH REPORT
Diffusion Pharma’s TSC Shows Encouraging Effects On Oxygenation
Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) has announced topline results from the Phase 1 trial of its lead product candidate, trans sodium crocetinate…
Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) ("Diffusion" or the "Company"), an innovative biopharmaceutical company developing novel therapies that enhance the body's ability to deliver